WallStreetZenWallStreetZen

NASDAQ: THMO
Thermogenesis Holdings Inc Stock Forecast, Predictions & Price Target

Analyst price target for THMO

Based on 1 analyst offering 12 month price targets for Thermogenesis Holdings Inc.
Min Forecast
$5.00+635.29%
Avg Forecast
$5.00+635.29%
Max Forecast
$5.00+635.29%

Should I buy or sell THMO stock?

Based on 1 analyst offering ratings for Thermogenesis Holdings Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their THMO stock forecasts and price targets.

THMO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-14

1 of 1

Forecast return on equity

Is THMO forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.83%

Forecast return on assets

Is THMO forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

THMO revenue forecast

What is THMO's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$16.9M+78.48%
Avg 2 year Forecast
$23.5M+149.02%
Avg 3 year Forecast
$25.6M+170.51%
THMO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

THMO revenue growth forecast

How is THMO forecast to perform vs Medical Devices companies and vs the US market?
Company
40.73%
Industry
8.17%
Market
9.94%
THMO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
THMO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

THMO vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
THMO$0.68$5.00+635.29%Buy
OPGN$0.52N/AN/A
INBS$2.69N/AN/A
AFIB$0.17N/AN/A
BIOL$0.15$2.20+1,386.49%Buy

Thermogenesis Holdings Stock Forecast FAQ

Is Thermogenesis Holdings Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: THMO) stock is to Buy THMO stock.

Out of 1 analyst, 0 (0%) are recommending THMO as a Strong Buy, 1 (100%) are recommending THMO as a Buy, 0 (0%) are recommending THMO as a Hold, 0 (0%) are recommending THMO as a Sell, and 0 (0%) are recommending THMO as a Strong Sell.

If you're new to stock investing, here's how to buy Thermogenesis Holdings stock.

What is THMO's revenue growth forecast for 2024-2026?

(NASDAQ: THMO) Thermogenesis Holdings's forecast annual revenue growth rate of 40.73% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.17%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.94%.

Thermogenesis Holdings's revenue in 2024 is $9,445,000.On average, 1 Wall Street analysts forecast THMO's revenue for 2024 to be $134,060,012, with the lowest THMO revenue forecast at $134,060,012, and the highest THMO revenue forecast at $134,060,012. On average, 1 Wall Street analysts forecast THMO's revenue for 2025 to be $187,049,386, with the lowest THMO revenue forecast at $187,049,386, and the highest THMO revenue forecast at $187,049,386.

In 2026, THMO is forecast to generate $203,193,529 in revenue, with the lowest revenue forecast at $203,193,529 and the highest revenue forecast at $203,193,529.

What is THMO's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: THMO) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of N/A.

What is THMO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year THMO price target, the average THMO price target is $5.00, with the highest THMO stock price forecast at $5.00 and the lowest THMO stock price forecast at $5.00.

The Wall Street analyst predicted that Thermogenesis Holdings's share price could reach $5.00 by Nov 14, 2024. The average Thermogenesis Holdings stock price prediction forecasts a potential upside of 635.29% from the current THMO share price of $0.68.

What is THMO's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: THMO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.